Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Glucagon; related peptides
Reexamination Certificate
2005-11-01
2010-12-07
Kosar, Andrew D (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Glucagon; related peptides
C514S002600, C424S551000
Reexamination Certificate
active
07847061
ABSTRACT:
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
REFERENCES:
patent: 5789379 (1998-08-01), Drucker et al.
patent: 6077949 (2000-06-01), Munroe et al.
patent: 6184201 (2001-02-01), Drucker et al.
patent: 7411039 (2008-08-01), Thim et al.
patent: 1231219 (2002-08-01), None
patent: WO 97/39091 (1997-10-01), None
patent: WO 9739031 (1997-10-01), None
patent: WO 02/066511 (2002-08-01), None
Jeppesen, et al., J. Nutr., 2003, 133, 3721-3724.
Jeppesen, et al., JPEN, 1999, 23, S101-S105.
Jeppesen et al. (Gastroenterology 2001;120:806-815).
K. N. Jeejeebhoy, “Short bowel syndrome: a nutritional and medical approach”, CMAJ; May 14, 2002, 168 (10), pp. 1297-11302.
Jeppesen et al.,Impaired Meal Stimulated Glucagon-Like. Peptide 2 Response in Ileal Resected Short Bowel Pateints with Intestinal Failure, GUT, 45:559-563 (1999).
Jeppesen et al.,Elevated Plasma Glucagon-like Peptide 1 and 2 Concentrations in Ileum Resected Short Bowel Patients with a Preserved Colon, GUT, 47:370-376 (2000).
Jeppesen et al.,ALX-0600, a Dipeptidyl Peptidase-IV Resistant Glucagon-like Peptide-2(GLP-2)Analog, Improves Intestinal Function in Short Bowel Syndrome(SBS)Pateints with a Jejunostomy, Gastroenterology 122:A-191 (2002).
Scott et al.,GLP-2 Augments the Adaptive Response to Massive intestinal Resection in Rat, Am. J. Physiol. (Gastrointest. Liver Physiol. 38): G911-G921 (1988).
Ferrone, et al., “Teduglutide for the treatment of short bowel syndrome”, The Annals of Pharmacotherapy, 2006, vol. 40, No. 6, 1105-1109.
International Preliminary Report on Patentability and Written Opinion issued in International Application No. PCT/US2005/039222 dated May 1, 2007.
International Search Report issued in International Application No. PCT/US2005/039222 dated Jul. 17, 2006.
Jeppesen, et al., “Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients”, Gut, vol. 54, No. 9, 2005, 1224-1231.
Yang, et al., “Novel Agents in the treatment of intestinal failure: humoral factors”, Gastroenterology, vol. 130, No. 2, 2006, S117-S121.
Blosch Consuelo Maria
Lopansri Jennifer
Marriott Thomas B.
Sanguinetti Elizabeth Lemaire
Gudibande Satyanarayana R
Kosar Andrew D
NPS Pharmaceuticals Inc.
Stoel Rives LLP
LandOfFree
Treatment of short bowel syndrome patients with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of short bowel syndrome patients with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of short bowel syndrome patients with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4199941